Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amgen (AMGN)
NASDAQ:AMGN
Holding AMGN?
Track your performance easily
AMGN Analyst Ratings
Moderate Buy
10 Buy
9 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AMGN Stock 12 Month Forecast
Average Price Target
$334.56
▲(19.36% Upside)
| Highest Price Target$405.00 | Average Price Target$334.56 | Lowest Price Target$256.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BMO Capital
Reiterated
01/29/25
Citi
Reiterated
01/28/25
RBC Capital
Assigned
01/24/25
Piper Sandler
Reiterated
01/23/25
Wells Fargo
Reiterated
01/21/25
Goldman Sachs
Reiterated
01/15/25
Truist Financial
Assigned
01/15/25
Jefferies
Reiterated
01/14/25
Bernstein
Reiterated
01/10/25
Oppenheimer
Reiterated
12/11/24
Bank of America Securities
$256
Sell
-8.67%
Downside
Initiated
12/10/24
Amgen reinstated with an Underperform at BofAAmgen reinstated with an Underperform at BofA
TD Cowen
$383
Buy
36.64%
Upside
Reiterated
12/02/24
TD Cowen Reaffirms Their Buy Rating on Amgen (AMGN)
Leerink Partners
$305
Hold
8.81%
Upside
Reiterated
11/27/24
We are lowering our PT from $352 (18x 2025E EPS of $19.55) to $305 (15x 2025E EPS of $20.33) and maintaining our Market Perform rating. We lowered our 5- yr (’25-’30) CAGR EPS from 8% to 4%, largely driven by higher investment spending assumptions. MariTide’s Ph2 results were positive, but only differentiated from LLY’s (OP) tirzepatide on administration (less frequent dosing) – see our initial note here. And MariTide’s full efficacy, safety, and tolerability profile has yet to be fully elucidated.
Morgan Stanley
$322
Hold
14.88%
Upside
Reiterated
11/26/24
Hold Rating on Amgen's Maritide Amid Uncertainties in Efficacy and Tolerability
Best Analysts Covering Amgen
Which Analyst Should I Follow If I Want to Buy AMGN and Sell After:
1 Month
xxx
Success Rate
15/29 ratings generated profit
Average Return
-0.50%
assigned a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 51.72% of your transactions generating a profit, with an average return of -0.50% per trade.
3 Months
xxx
Success Rate
21/34 ratings generated profit
Average Return
+4.66%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.76% of your transactions generating a profit, with an average return of +4.66% per trade.
1 Year
Success Rate
23/34 ratings generated profit
Average Return
+11.34%
reiterated a buy rating 2 months ago
Copying Yaron Werber's trades and holding each position for 1 Year would result in 67.65% of your transactions generating a profit, with an average return of +11.34% per trade.
2 Years
xxx
Success Rate
41/53 ratings generated profit
Average Return
+17.83%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.36% of your transactions generating a profit, with an average return of +17.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AMGN Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
0
0
0
0
Buy
27
40
43
38
29
Hold
18
27
34
26
18
Sell
2
2
1
1
1
Strong Sell
0
0
0
0
0
total
47
69
78
65
48
Each month's total comprises the sum of three months' worth of ratings.
AMGN Financial Forecast
AMGN Stock Forecast FAQ
What is AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is $334.56.
What is AMGN’s upside potential, based on the analysts’ average price target?
Amgen has 19.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AMGN a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy which is based on 10 buy ratings, 9 hold ratings and 1 sell ratings.
What is Amgen’s price target?
The average price target for Amgen is $334.56. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $405.00 ,the lowest forecast is $256.00. The average price target represents 19.36% Increase from the current price of $280.3.
The highest analyst price target is $405.00 ,the lowest forecast is $256.00. The average price target represents 19.36% Increase from the current price of $280.3.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of AMGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.